semaglutide flow study chart. †Participants who initiated oral and Effects of semaglutide with and

For instance, the American Diabetes Association only recommends the use of GLP-1 drugs for weight loss for those with a body mass index, or BMI, of at least 30, or among those with a BMI of 27 or greater if they have at least one other condition such as type 2 diabetes, hypertension or high cholesterol

Does not include your questions answered by HHI Certified Trainers on the private Clinician's Companion Community Board Does not include access to Live Online Learning Events with Dr DeRosa and our other trainers Does not include professional recognition via inclusion in Certified Clinician Directory and digital certification

Patients taking prescription medications for weight management or diabetes should not replace these treatments with probiotic supplements

Important: Layering multiple sprays increases overall exposure to active compounds

The debate surrounding GLP-1 medicines presents a remarkably similar challenge, but in a less visible context